Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
magnesium + riboflavin
- Development stage
- Preclinical
- Lead developer
- Akeso Health Sciences
- Administration
- Oral
01
Overview
A dietary supplement combination containing magnesium and riboflavin (vitamin B2), often formulated with additional ingredients such as feverfew or Coenzyme Q10. This combination is primarily used for migraine prevention and to address nutritional deficiencies. Magnesium supports normal nerve and muscle function, while riboflavin aids in cellular energy production and may help reduce migraine frequency and severity.
- Brand names
- MigreLief Original FormulaMigrantaMigraventDolovent
02
Targets
RFK (Riboflavin kinase)NMDAR (Glutamate receptor ionotropic, NMDA)
Beyond the preview
Go deeper on magnesium + riboflavin.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on magnesium + riboflavin.